Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 9/2013

01-09-2013 | Case Report

Necrosis of Large Hepatocellular Carcinoma Induced by Preoperative Portal Vein Embolization: A Case Report

Authors: Akira Yasuda, Tsuyoshi Kurokawa, Noiku Nakao, Hiroyuki Fujisaki, Keiichi Ando, Nobuhiro Ito, Norifumi Ohashi, Takashi Arikawa, Takahisa Tainaka, Hiroshi Nagata, Kazuyoshi Suzumura, Toshiaki Nonami

Published in: Digestive Diseases and Sciences | Issue 9/2013

Login to get access

Excerpt

Preoperative portal vein embolization (PVE) generally not only increases future liver remnants (FLR) but also stimulates the growth of hepatocellular carcinoma (HCC) in embolized lobes. We describe an extremely rare case in which PVE induced necrosis of HCC. …
Literature
1.
Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma. Surgery. 1990;107:521–527.PubMed
2.
Hayashi S, Baba Y, Ueno K, et al. Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization. Acta Radiol. 2007;48:721–727.PubMedCrossRef
3.
Suzuki M, Maeyama S, Okuse N, et al. A case of complete necrosis of well-differentiated early hepatocellular carcinoma by percutaneous transhepatic portal embolization. Hepatol Res. 2002;22:74–82.PubMedCrossRef
4.
Okabe H, Beppu T, Ishiko T, et al. Preoperative portal vein embolization (PVE) for patients with hepatocellular carcinoma can improve resectability and may improve disease-free survival. J Surg Oncol. 2011;104:641–646.PubMedCrossRef
5.
Kaczynski J, Hansson G, Remotti H, Wallerstedt S. Spontaneous regression of hepatocellular carcinoma. Histopathology. 1998;32:147–150.PubMedCrossRef
6.
Bastawrous S, Kogut MJ, Bhargava P. Spontaneous regression of hepatocellular carcinoma in a cirrhotic patient: possible vascular hypothesis. Singapore Med J. 2012;53:218–221.
7.
Nagino M, Nimura Y, Kamiya J, Kanai M, Hayakawa N, Yamamoto H. Immediate increase in arterial blood flow in embolized hepatic segments after portal vein embolization: CT demonstration. AJR Am J Roentgenol. 1998;171:1037–1039.PubMedCrossRef
8.
Zalinski S, Scatton O, Randone B, Vignaux O, Dousset B. Complete hepatocellular carcinoma necrosis following sequential porto-arterial embolization. World J Gastroenterol. 2008;14:6869–6972.PubMedCrossRef
9.
Vilgrain V, Sibert A, Zappa M, Belghiti J. Sequential arterial and portal vein embolizaion in patients with cirrhosis and hepatocellular carcinoma: the Hospital Beaujon experience. Semin Intervent Radiol. 2008;25:155–161.PubMedCrossRef
Metadata
Title
Necrosis of Large Hepatocellular Carcinoma Induced by Preoperative Portal Vein Embolization: A Case Report
Authors
Akira Yasuda
Tsuyoshi Kurokawa
Noiku Nakao
Hiroyuki Fujisaki
Keiichi Ando
Nobuhiro Ito
Norifumi Ohashi
Takashi Arikawa
Takahisa Tainaka
Hiroshi Nagata
Kazuyoshi Suzumura
Toshiaki Nonami
Publication date
01-09-2013
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2013
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-013-2674-1

Other articles of this Issue 9/2013

Digestive Diseases and Sciences 9/2013 Go to the issue

Editorial

Gastrointestinal Bleeding: Who Needs Urgent Endoscopic Intervention?

Original Article

The Effect of Acute Hypoxia on Short-Circuit Current and Epithelial Resistivity in Biopsies from Human Colon

Editorial

Activation of Signaling Pathways Following Intestinal Resection: Turning It Up a Notch?

Original Article

The Jagged-1/Notch-1/Hes-1 Pathway Is Involved in Intestinal Adaptation in a Massive Small Bowel Resection Rat Model

Original Article

Relationship Between Neutrophil Gelatinase-Associated Lipocalin (NGAL) Levels and Inflammatory Bowel Disease Type and Activity

Original Article

False Negative Fecal Occult Blood Test May Be Associated with Increased Mortality from Colorectal Cancer
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits